Gene Therapy Research Advances in Neurology and Otolaryngology

Gene therapy research is advancing treatment options for patients with rare and devastating neurological disorders, with work focusing on conditions like Alzheimer's and Parkinson's Disease, both of which affect over 8 million Americans combined. The approach involves injecting healthy growth genes to help recover dying brain cells.

The treatment uses viral vectors infused in the brain to deliver genes of interest into cells. These vectors are not pathogenic, and cells that take those genes produce a protein, allowing treatment of an entire circuit from a very small area. One of the main delivery methods is convection-enhanced delivery, which involves inserting catheters in the brain down to the submillimeter. Catheters are placed in the brain and infused under a little bit of pressure, helping larger molecules like viral particles or big chemotherapy agents to distribute more broadly in the brain.

An advantage to infusing growth genes into the brain instead of stem cells or a blood transfusion is the strength of the genes. Currently, growth genes infused by blood can be diluted and cause a negative immune reaction and don't have a specific target.

Neurological gene therapy benefits from the high level of imagery possible from brain scans, many of which offer insights into the procedures in the research phase. Patients can be monitored while asleep in the intraoperative MRI, with surgeons able to actually track the distribution of where they're treating and get real-time feedback. This allows surgeons to modify and do things on the fly.

Brain tumors are very difficult to treat, and researchers are always looking to push that boundary a little bit in terms of overall survival by doing clinical trials. The research aims to improve the field in a much more lasting way beyond impacting a singular patient.

In the field of otolaryngology and head and neck surgery, the expansion of research into areas such as gene therapy, advanced neurotology, and precision oncology necessitates a focused forum for dialogue and discovery. A new peer-reviewed open-access journal, ENT Discovery, has been launched to publish cutting-edge original research, authoritative reviews, and insightful commentaries that address the full spectrum of the specialty—from hearing restoration and vestibular science to airway reconstruction and head and neck oncology. The journal places core emphasis on fostering interdisciplinary collaboration and accelerating the translation of laboratory findings into clinical applications that directly improve patient care.